Formulation of sustained-release tablets. II. Hydrophilic matrices
Buri, P.; Doelker, E.
Pharmaceutica Acta Helvetiae 55(7-8): 189-197
1980
ISSN/ISBN: 0031-6865 PMID: 7433467 Document Number: 157659
Document emailed within 1 workday
Related Documents
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350Wahab, A.; Khan, G.M.; Akhlaq, M.; Khan, N.R.; Hussain, A.; Khan, M.F.; Khan, H. 2011: Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism Die Pharmazie 66(9): 677-683
Leucuta, S.E. 1988: The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man Die Pharmazie 43(12): 845-848
Peña Romero, A.; Poncet, M.; Jinot, J.C.; Chulia, D. 1988: Statistical optimization of sustained-release preparations of sodium diclofenac in the form of inert matrices. i Pharmaceutica Acta Helvetiae 63(11): 309-314
Witchitz, S.; Moisson, P.; Kolsky, H. 1984: A comparative trial of ordinary metoprolol tablets and metoprolol sustained-release tablets in hypertensive patients at rest and on exercise Pharmatherapeutica 3(8): 566-572
Emeje, M.O.; Kunle, O.O.; Ofoefule, S.I. 2006: Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix Acta Pharmaceutica 56(3): 325-335
Cleophas, T.J.; Niemeyer, M.G.; Zwinderman, A.H.; van der Wall, E.E. 2000: Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group Angiology 51(8): 631-638
Johnson, D.A.; O'Donnell, J.P.; Choulis, N.H. 1978: NMR studies of sustained release methadone tablets Die Pharmazie 33(12): 813
Araico, A.; Saadeddin, A.; Torres-Molina, F.; Peris, J.E. 2009: In vivo evaluation of a new sustained-release formulation of morphine Die Pharmazie 64(10): 653-655
Li, D.-Y.; Liu, X.-Q.; Feng, W.-H.; Wang, Z.-M.; Yi, H.; Meng, Q.-J. 2013: Study on application of bioassay method in drug-release evaluation in vitro of Salvia miltiorrhiza hydrophilic gel matrix tablets Zhongguo Zhong Yao Za Zhi 38(22): 3880-3887
Xi, N.Z.; Tu, Z.P.; Pei, Y.Y.; Liu, D.L.; Ma, L.S.; Yang, X.Y. 1981: Calcium alginate as matrix for sustained release tablets Yao Xue Xue Bao 16(4): 277-282
Mellstrand, T.; Svedmyr, N.; Fagerström, P.O. 1980: Absorption of theophylline from conventional and sustained-release tablets European Journal of Respiratory Diseases. Supplement 109: 54-60
Ferrari, M.; Olivieri, M.; Romito, D.; Biasin, C.; Barozzi, E.; Bassetti, S. 1991: Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline Rivista Europea Per le Scienze Mediche e Farmacologiche 13(5-6): 269-274
Newth, C.J.; Isles, A.F. 1984: Assessment of a sustained release capsule and a tablet formulation of theophylline British Journal of Clinical Practice. Suppl 35: 53-54
Inouye, K.; Machida, Y.; Nagai, T. 1987: Sustained release tablets based on chitosan and carboxymethylcellulose sodium Drug Design and Delivery 1(4): 297-305
Sharma, P.L.; Sharma, R.M. 1979: Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man International Journal of Clinical Pharmacology and Biopharmacy 17(9): 394-396
Eraga, S.O.; Arhewoh, M.I.; Iwuagwu, M.A.; Ukponahiusi, O.E. 2015: Formulation and in vitro release studies of pegylated mucin based matrix tablets Pakistan Journal of Pharmaceutical Sciences 28(1): 113-118
Ihlen, H.; Skomedal, T.; Stafsnes, H.; Ditlefsen, E.M. 1975: Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction Current Therapeutic Research 17(3): 257-262
Jonkman, J.H.; van der Boon, W.J.; Schoenmaker, R.; Holtkamp, A.; Thürkow-Luikens, A.J. 1984: The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 506-510
Harrison, L.I.; French, I.W.; Mildon, C.A. 1982: Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans Clinical Therapeutics 4(6): 489-496